RAPAd®

The RAPAd® method of Adenovirus construction, developed by ViraQuest Inc. scientists, has been used by other scientists around the world.

Request Quote

Confidentiality

 

Learn More

Quality Control

Plaque forming units guarantee. Non-detectable RCA.

Learn More

Turnaround Time

Sub-cloning to finished particles in about four weeks.

Learn More

Dual Expressers

Multiple transgene expression in a single virus.

Learn More

Tag Archives: Vaccine

Differential, type I interferon-mediated autophagic trafficking of hepatitis C virus proteins in mouse liver.

Authors: Desai MM, Gong B, Chan T, Davey RA, Soong L, Kolokoltsov AA, Sun J.
Citation: Gastroenterology. 2011 Aug;141(2):674-85, 685.e1-6.

read more

Cold-adapted influenza and recombinant adenovirus vaccines induce cross-protective immunity against pH1N1 challenge in mice.

Authors: Soboleski MR, Gabbard JD, Price GE, Misplon JA, Lo CY, Perez DR, Ye J, Tompkins SM, Epstein SL.
Citation: PLoS One. 2011;6(7):e21937.

read more

DNA/Ad5 vaccination with SIV epitopes induced epitope-specific CD4? T cells, but few subdominant epitope-specific CD8? T cells.

Authors: Vojnov L, Bean AT, Peterson EJ, Chiuchiolo MJ, Sacha JB, Denes FS, Sandor M, Fuller DH, Fuller JT, Parks CL, McDermott AB, Wilson NA, Watkins DI.
Citation: Vaccine. 2011 Oct 6;29(43):7483-90.

read more

Vaccine-induced anti-tuberculosis protective immunity in mice correlates with the magnitude and quality of multifunctional CD4 T cells.

Authors: Derrick SC, Yabe IM, Yang A, Morris SL.
Citation: Vaccine. 2011 Apr 5;29(16):2902-9.

read more

Single-dose mucosal immunization with a candidate universal influenza vaccine provides rapid protection from virulent H5N1, H3N2 and H1N1 viruses.

Authors: Price GE, Soboleski MR, Lo CY, Misplon JA, Quirion MR, Houser KV, Pearce MB, Pappas C, Tumpey TM, Epstein SL.
Citation: PLoS One. 2010 Oct 4;5(10):e13162.

read more

Genetic control of immune responses to influenza A matrix 2 protein (M2).

Authors: Misplon JA, Lo CY, Gabbard JD, Tompkins SM, Epstein SL.
Citation: Vaccine. 2010 Aug 16;28(36):5817-27.

read more

A practical influenza neutralization assay to simultaneously quantify hemagglutinin and neuraminidase-inhibiting antibody responses.

Authors: Hassantoufighi A, Zhang H, Sandbulte M, Gao J, Manischewitz J, King L, Golding H, Straight TM, Eichelberger MC.
Citation: Vaccine. 2010 Jan 8;28(3):790-7.

read more

Comparison of vaccines for induction of heterosubtypic immunity to influenza A virus: cold-adapted vaccine versus DNA prime-adenovirus boost strategies

Authors: Lo CY, Wu Z, Misplon JA, Price GE, Pappas C, Kong WP, Tumpey TM, Epstein SL
Citation: Vaccine 2008 Apr 16 26 17: 2062-2072

read more

Development of an adenoviral vaccine against E6 and E7 oncoproteins to prevent growth of human papillomavirus-positive cancer

Authors: Lee DW, Anderson ME, Wu S, Lee JH
Citation: Arch Otolaryngol Head Neck Surg 2008 Dec 134 12: 1316-1323

read more

The safety of post-exposure vaccination of mice infected with Mycobacterium tuberculosis

Authors: Derrick SC, Perera LP, Dheenadhayalan V, Yang A, Kolibab K, Morris SL
Citation: Vaccine 2008 Nov 11 26 48: 6092-6098

read more
  • Page 1 of 2
  • 1
  • 2
  • >